Griffin Funding Sets Sights on $3B Non-QM Landmark With New SVP of Growth, John Jones

Leadership promotion

Big moves are unfolding in the non-QM lending world, and they’re coming from one of the industry’s most watched innovators: Griffin Funding. The company announced that John Jones—known for his ability to scale organizations with precision—has officially stepped into the role of Senior Vice President of Growth and EOS Integrator.

A Leadership Shift Aimed at Massive Expansion

After serving as Griffin Funding’s fractional integrator and COO since April 2025, Jones will now take the reins full-time beginning December 1. According to CEO Bill Lyons, Jones has already brought “tremendous structure and clarity” to the operation—a strong endorsement as the company gears up for its next chapter.

And that next chapter is bold: driving Griffin Funding to $3 billion in annual non-QM loan volume by 2030.

What Jones Will Lead Next

Jones’s new mission focuses on strengthening leadership, boosting production efficiency, expanding into new markets, and optimizing both sales and operational channels. In short, he’s becoming the architect behind Griffin’s next phase of smart, scalable growth.

As Chloe Shubin, VP of Strategy, puts it: “John’s impact is felt across every department… He helps align strategy with execution.

A Growing Footprint Backed by Solid Numbers

Griffin Funding already operates active offices in San Diego, Irvine, and Scottsdale. With $72.5 million in warehouse line liquidity powering its lending engine and $346.3 million in closed deal volume recorded as of November 17, the company appears to be positioned for a breakout decade ahead.

For readers across real estate, mortgage, finance, and compliance-driven professions, this move is absolutely one to watch. Leadership shifts like this often trigger new innovation, new hiring waves, and fresh professional development opportunities throughout the industry.

And if you’re looking to strengthen your own professional edge in high‑growth fields like real estate, mortgage, insurance, finance, or medical licensing, Cameron Academy is here to help you build the skills, certifications, and licenses that move careers forward.

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

Telehealth: Bridging the Gap in Healthcare Access

Telehealth has emerged as a vital tool in providing equitable healthcare access by increasing the availability of specialists and reducing transportation barriers.

By |December 24, 2024|Categories: Article, Healthcare, Technology|Tags: , |0 Comments

Revolutionizing Liver Cancer Diagnosis: An Emerging Market Potential

Liver cancer continues to be a significant health challenge globally, ranking as one of the leading causes of cancer-related deaths.

By |December 24, 2024|Categories: Article, Healthcare, Market Analysis|Tags: , |0 Comments

World Cities Day 2024: A Global Movement Towards Sustainable Urban Futures

In the spirit of World Cities Day, celebrated on October 31st, cities worldwide are embracing the theme "Youth Leading Climate and Local Action for Cities." This theme underscores the pivotal role of young leaders in driving sustainable urban solutions, a movement gaining momentum through community-led initiatives and progressive policies.

The Road Ahead: Self-Driving Cars Reshape the Automotive Industry

"Goldman Sachs envisions a scenario where AV sales, particularly those with Level 3 automation or higher, could account for 60% of all light vehicle sales by 2040. Even in a less optimistic scenario, AVs are expected to comprise nearly 40% of new sales."

Semaglutide: A Promising Ally Against Alzheimer’s?

A groundbreaking study by researchers at Case Western Reserve School of Medicine reveals semaglutide, a common diabetes and weight-loss drug, may significantly reduce the risk of Alzheimer’s disease in individuals with type 2 diabetes.

By |December 23, 2024|Categories: Article, Health, Research|Tags: |0 Comments

Revolutionizing Healthcare: The AI Transformation in Louisiana

In the heart of Louisiana, a digital revolution is underway, reshaping the landscape of healthcare diagnostics with the power of artificial intelligence (AI). AI is not just a tool but a transformative force, enhancing diagnostic accuracy, improving patient outcomes, and reducing costs.